|
Name |
Dioctyl adipate
|
Molecular Formula | C22H42O4 | |
IUPAC Name* |
dioctyl hexanedioate
|
|
SMILES |
CCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC
|
|
InChI |
InChI=1S/C22H42O4/c1-3-5-7-9-11-15-19-25-21(23)17-13-14-18-22(24)26-20-16-12-10-8-6-4-2/h3-20H2,1-2H3
|
|
InChIKey |
NEHDRDVHPTWWFG-UHFFFAOYSA-N
|
|
Synonyms |
Dioctyl adipate; Dioctyl hexanedioate; 123-79-5; Di-n-octyl adipate; Hexanedioic acid, dioctyl ester; Dicaprylyl adipate; Adipic acid, dioctyl ester; Hexanedioic acid, 1,6-dioctyl ester; 1,6-dioctyl hexanedioate; NSC 16201; 2BD76YG9SI; NSC-16201; HSDB 366; EINECS 204-652-9; UNII-2BD76YG9SI; AI3-17824; Adiimoll DO; Adipic acid dioctyl; SCHEMBL15509; Dioctyl ester hexanedioic acid; Hexanedioic acid dioctyl ester; Adipic acid, bis-n-octyl ester; DTXSID2021606; FEMA NO. 4476; Adipic acid di-n-octyl ester 5g; DIOCTYL ADIPATE [WHO-DD]; Dioctyl ester of hexanedioic acid; CHEBI:168986; DI-N-OCTYL ADIPATE [HSDB]; NSC16201; BBL010773; LMFA07010840; MFCD00072258; STK584146; ZINC59301183; AKOS005507485; AS-62479; FT-0621921; H10660; J-004984; J-520375; Q4731704
|
|
CAS | 123-79-5 | |
PubChem CID | 31271 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 370.6 | ALogp: | 7.4 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 21 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 52.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 26 | QED Weighted: | 0.197 |
Caco-2 Permeability: | -4.813 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.113 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 0.999 |
Blood-Brain-Barrier Penetration (BBB): | 0.081 | Plasma Protein Binding (PPB): | 96.40% |
Volume Distribution (VD): | 0.962 | Fu: | 1.64% |
CYP1A2-inhibitor: | 0.617 | CYP1A2-substrate: | 0.169 |
CYP2C19-inhibitor: | 0.483 | CYP2C19-substrate: | 0.057 |
CYP2C9-inhibitor: | 0.321 | CYP2C9-substrate: | 0.842 |
CYP2D6-inhibitor: | 0.23 | CYP2D6-substrate: | 0.035 |
CYP3A4-inhibitor: | 0.57 | CYP3A4-substrate: | 0.078 |
Clearance (CL): | 8.835 | Half-life (T1/2): | 0.413 |
hERG Blockers: | 0.431 | Human Hepatotoxicity (H-HT): | 0.012 |
Drug-inuced Liver Injury (DILI): | 0.184 | AMES Toxicity: | 0.003 |
Rat Oral Acute Toxicity: | 0.021 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.965 | Carcinogencity: | 0.122 |
Eye Corrosion: | 0.962 | Eye Irritation: | 0.92 |
Respiratory Toxicity: | 0.296 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001218 | 0.750 | D00MLW | 0.596 | ||||
ENC003079 | 0.728 | D07ILQ | 0.489 | ||||
ENC001234 | 0.718 | D00FGR | 0.461 | ||||
ENC000765 | 0.674 | D0Z5SM | 0.455 | ||||
ENC001202 | 0.620 | D0O1PH | 0.429 | ||||
ENC001236 | 0.620 | D05ATI | 0.424 | ||||
ENC000419 | 0.617 | D00AOJ | 0.410 | ||||
ENC000575 | 0.614 | D0T9TJ | 0.398 | ||||
ENC000258 | 0.612 | D0AY9Q | 0.398 | ||||
ENC001243 | 0.609 | D0Z1QC | 0.371 |